BIOLIFE SOLUTIONS, INC. (NASDAQ:BLFS) Files An 8-K Results of Operations and Financial Condition

BIOLIFE SOLUTIONS, INC. (NASDAQ:BLFS) Files An 8-K Results of Operations and Financial Condition

Story continues below

Item 2.02

Results of Operations and Financial
Condition.

On March 9, 2017, BioLife Solutions, Inc. (the Company) issued a
press release announcing the financial results and operational
highlights for the fourth quarter and full year 2016. A copy of
the press release is furnished as Exhibit 99.1 to this current
report on Form 8-K.

Item 9.01 Financial Statements and Exhibits.
(d) Exhibits
ExhibitNo. Description
99.1 Press release, dated March 9, 2017


About BIOLIFE SOLUTIONS, INC. (NASDAQ:BLFS)

BioLife Solutions, Inc. (BioLife) is engaged in the developing, manufacturing and marketing a portfolio of biopreservation tools and services for cells, tissues and organs, including clinical grade cell and tissue hypothermic storage and cryopreservation freeze media and a related cloud hosted biologistics cold chain management application for shippers. The Company’s product offerings include hypothermic storage and cryopreservation freeze media products for cells, tissues, and organs; generic blood stem cell freezing and cell thawing media products; custom product formulation and custom packaging services; cold chain logistics services incorporating precision thermal packaging products and cloud-hosted Web applications, and contract aseptic manufacturing formulation, fill and finish services of liquid media products. Its products include HypoThermosol FRS, CryoStor, BloodStor, Cell Thawing Media, PrepaStor and biologistex cold-chain management service.

BIOLIFE SOLUTIONS, INC. (NASDAQ:BLFS) Recent Trading Information

BIOLIFE SOLUTIONS, INC. (NASDAQ:BLFS) closed its last trading session up +0.03 at 2.24 with 59,572 shares trading hands.

An ad to help with our costs